Fig. 7
From: Carvacrol ameliorates acute campylobacteriosis in a clinical murine infection model
Extra-intestinal pro-inflammatory mediator secretion following carvacrol treatment of C. jejuni infected mice. Starting 4 days prior peroral C. jejuni infection on days 0 and 1, secondary abiotic IL-10−/− mice were treated with synthetic carvacrol (CARVA; white boxes) or placebo (PLC; grey boxes) via the drinking water. a, c, e IFN-γ and b, d, f TNF concentrations were measured in supernatants of ex vivo biopsies derived from a, b liver, c, d kidneys and e, f lungs at day 6 post-infection. Naive mice served as uninfected controls. The total range, significance levels (p-values) determined by the Mann–Whitney U test and numbers of analyzed animals (in parentheses) are indicated. Data were pooled from four independent experiments